[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2058100T3 - Vacuna combinada. - Google Patents

Vacuna combinada.

Info

Publication number
ES2058100T3
ES2058100T3 ES87200709T ES87200709T ES2058100T3 ES 2058100 T3 ES2058100 T3 ES 2058100T3 ES 87200709 T ES87200709 T ES 87200709T ES 87200709 T ES87200709 T ES 87200709T ES 2058100 T3 ES2058100 T3 ES 2058100T3
Authority
ES
Spain
Prior art keywords
combined vaccine
coli
protection against
herpes viruses
herpes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87200709T
Other languages
English (en)
Inventor
Heinrich Dieter Lutticken
Nicolaas Visser
Eric Onno Rijke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of ES2058100T3 publication Critical patent/ES2058100T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE ENCONTRO QUE LAS VACUNAS QUE CONTENIAN E.COLI Y VIRUS DEL HERPES NO PROPORCIONABAN UNA ADECUADA PROTECCION CONTRA LAS SUBSIGUIENTES INFECCIONES CON VIRUS DEL HERPES. LA PRESENTE INVENCION CONCIERNE A UNA VACUNA COMBINADA DE E.COLI Y VIRUS DEL HERPES, QUE PROPORCIONA PROTECCION CONTRA AMBOS TIPOS DE AGENTES PATOGENOS.
ES87200709T 1986-04-21 1987-04-15 Vacuna combinada. Expired - Lifetime ES2058100T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8601001 1986-04-21

Publications (1)

Publication Number Publication Date
ES2058100T3 true ES2058100T3 (es) 1994-11-01

Family

ID=19847903

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87200709T Expired - Lifetime ES2058100T3 (es) 1986-04-21 1987-04-15 Vacuna combinada.

Country Status (9)

Country Link
US (1) US4788056A (es)
EP (1) EP0246680B1 (es)
JP (1) JP2536751B2 (es)
CA (1) CA1287579C (es)
DE (1) DE3786301T2 (es)
DK (1) DK196687A (es)
ES (1) ES2058100T3 (es)
HU (1) HU200696B (es)
ZA (1) ZA872532B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583112A (en) * 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
US5069901A (en) * 1988-02-03 1991-12-03 Jones Elaine V Preparation of a recombinant subunit vaccine against pseudorabies infection
JPH085804B2 (ja) * 1988-04-28 1996-01-24 財団法人化学及血清療法研究所 Ａ型及びｂ型肝炎混合アジュバントワクチン
EP0382271B1 (en) * 1989-02-04 1994-12-21 Akzo Nobel N.V. Tocols as adjuvant in vaccine
ZA927037B (en) * 1991-09-30 1993-03-29 Akzo Nv Respiratory disease vaccine for cats.
US6872398B2 (en) * 1995-12-22 2005-03-29 The United States Of America As Represented By The Secretary Of The Army Conjugate vaccine against gram-negative bacterial infections
ES2327693T3 (es) * 1997-08-29 2009-11-02 Antigenics Inc. Composiciones que comprenden el adyvante qs-21 y polisorbato o ciclodextrina excipiente.
ATE385808T1 (de) * 1999-12-21 2008-03-15 Merial Sas Mindestens ein cryptosporidium parvum-antigen und mindestens ein antigen eines anderen darmkrankheitserregers enthaltende zusammensetzungen und impfstoffe
JP2005514041A (ja) * 2002-01-11 2005-05-19 イーデー−レリースタツト・インステイテユート・フオール・デイールホウデライ・エイ・デイールゲゾントハイト・ベー・ベー ミコバクテリウム・パラツベルクローシス感染の診断薬及びワクチン
DE602005011041D1 (de) * 2004-07-23 2008-12-24 Advisys Inc Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort
FR2878746B1 (fr) 2004-12-02 2007-02-23 Vetoquinol Sa Sa Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792256C3 (de) * 1968-08-10 1979-07-05 Kali-Chemie Pharma Gmbh, 3000 Hannover Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen
US3873422A (en) * 1972-10-30 1975-03-25 Univ Nebraska Vaccine for neonatal calf diarrhea
SE419500B (sv) * 1972-10-30 1981-08-10 Univ Nebraska Forfarande for attenuering av ett koronavirusliknande kalvdiarrevirus for framstellning av kalvdiarrevaccin
US4298597A (en) * 1979-09-04 1981-11-03 University Of Saskatchewan Vaccine for diarrhea caused by E. coli
US4440748A (en) * 1982-04-03 1984-04-03 Merck & Co., Inc. Strain of Escherichia coli by bacterial conjugation
ZA84467B (en) * 1983-02-01 1984-09-26 Upjohn Co Pseudorabies vaccine
NL8301996A (nl) * 1983-06-06 1985-01-02 Duphar Int Res Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.
NL8303501A (nl) * 1983-10-12 1985-05-01 Centraal Diergeneeskundig Inst Deletiemutant van een herpesvirus en vaccin, dat dit virus bevat.
FR2569984B1 (fr) * 1984-09-12 1987-08-14 Anvar Molecule synthetique contenant une pluralite d'epitopes distincts, procede pour son obtention et application a la production de polyvaccins
US4657761A (en) * 1985-06-05 1987-04-14 Pinto Cesar M Polyvalent non-specific immuno-stimulating vaccine and method

Also Published As

Publication number Publication date
JPS62267239A (ja) 1987-11-19
HU200696B (en) 1990-08-28
DK196687D0 (da) 1987-04-15
ZA872532B (en) 1987-11-25
DK196687A (da) 1987-10-22
DE3786301T2 (de) 1993-09-30
CA1287579C (en) 1991-08-13
US4788056A (en) 1988-11-29
HUT43792A (en) 1987-12-28
EP0246680B1 (en) 1993-06-23
JP2536751B2 (ja) 1996-09-18
DE3786301D1 (de) 1993-07-29
EP0246680A1 (en) 1987-11-25

Similar Documents

Publication Publication Date Title
ES2083764T3 (es) Vacuna contra el sindrome respiratorio reproductivo porcino (srrp) y diagnostico.
ES2058100T3 (es) Vacuna combinada.
PT88930A (pt) Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem
ES2057191T5 (es) Metodo de produccion para una composicion que contiene proteinas.
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
ATE79548T1 (de) Herpes simplex virus subunitimpfstoff.
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
ES2130189T3 (es) Vacunas de virus sincitial respiratorio (rsv) mutante que contienen dicho virus y procedimientos de uso.
ES2141093T3 (es) Herpesvirus equinos (ehv) que contienen adn ajeno, procedimiento para su obtencion y su empleo en vacunas.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
ES2099164T3 (es) Vacuna de glicoproteina de ehv-4.
DK0777669T3 (da) 4-[2-amino-6-(cyclopropylamino)-9H-purin-yl]-2-cyclopenten-1-methanolsuccinat som antiviralt middel
MX9304349A (es) Vacuna antirrabica no virulenta.
DE3853672D1 (de) Nichtzurückschlagende RNS-Viren.
ES2061165T3 (es) Vacuna para la proteccion de las aves de corral frente a la enfermedad de marek.
ES2055610T3 (es) Vacuna contra hrsv.
ES2056054T3 (es) Uso de linfocitos t activados para preparar una composicion farmaceutica para el tratamiento del sida.
FI943295A (fi) Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit
SE7904840L (sv) Antiviralt verksamma t-rna-preparat
ES2084587T3 (es) Arn virus no revertientes.
ES2124258T3 (es) Produccion del virus de la hepatitis a.
ES2055687T3 (es) Vacuna de virus.
OA09519A (fr) D-acide aspartique b-hydroxamate en tant que medicament

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 246680

Country of ref document: ES